or
forgot password
  • cancer clinical trials in birmingham, AL

  • BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma
    1200.36.0016 Boehringer Ingelheim Investigational Site
    Birmingham, Alabama
    Glioma
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
    Airway Epithelium Gene Expression: AEGIS II
    University of Alabama
    Birmingham, Alabama
    Lung Cancer
    Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer
    Brachytherapy Site: Urology Centers of Alabama
    Birmingham, Alabama 35209
    Prostate Cancer
    Neuropsychological and Behavioral Testing in Young Patients With Cancer
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Tuberous Sclerosis, Subependymal Giant Cell Astrocytoma
    Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
    Novartis Investigative Site
    Birmingham, Alabama 35294
    Tuberous Sclerosis Complex (TSC), Lymphangioleiomyomatosis (LAM)
    Determining Predictors of Safe Discontinuation of Anti-TNF Treatment in JIA
    Children's Hospital of Alabama
    Birmingham, Alabama 35233
    Juvenile Idiopathic Arthritis
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma
    Site Reference ID/Investigator# 18801
    Birmingham, Alabama 35243
    Melanoma, Metastatic Melanoma, Skin Cancer
    Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Head and Neck Cancer, Pharyngeal Cancer, Laryngeal Cancer
    Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Adult Rhabdomyosarcoma, Adult Synovial Sarcoma, Childhood Hepatoblastoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adrenocortical Carcinoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Retinoblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
    University of Alabama
    Birmingham, Alabama
    Rheumatoid Arthritis
    Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
    UAB Comprenhensive Cancer Center at University of Alabama
    Birmingham, Alabama 35294
    Metastatic Pancreatic Cancer
    A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Disease, Hodgkin
    Treatment With Pazopanib for Neoadjuvant Breast Cancer
    GSK Investigational Site
    Birmingham, Alabama 35209
    Neoplasms, Breast
    Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Ovarian Cancer
    A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
    The University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Neurofibromatosis Type 1
    Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Small Cell Lung Cancer, Extensive Stage Lung Cancer, Chemonaive
    Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Lung Cancer
    A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Malignant Melanoma
    A Phase 2 Open Label Trial of Brentuximab Vedotin (SGN-35) for Systemic Anaplastic Large Cell Lymphoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Leukemia
    Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma
    Pfizer Investigational Site
    Birmingham, Alabama 35205
    Lymphoma
    A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
    Birmingham Hematology and Oncology

    Trial Locations
    Birmingham Hematology and Oncology
    Birmingham Hematology and Oncology - Pilot
    Birmingham Hematology and Oncology - Princeton
    Birmingham Hematology and Oncology - Montclair
    Birmingham Hematology and Oncology - Brookwood
    Breast Cancer
    Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
    Children's Hospital of Alabama at University of Alabama at Birmingham
    Birmingham, Alabama 35233
    Leukemia, Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific
    Study of Kidney Tumors in Young Patients
    Children's Hospital of Alabama at University of Alabama at Birmingham
    Birmingham, Alabama 35233
    Kidney Cancer, Nonneoplastic Condition
    Collecting and Storing Tissue From Young Patients With Cancer
    Children's Hospital of Alabama at University of Alabama at Birmingham
    Birmingham, Alabama 35233
    Cancer
    Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
    Children's Hospital of Alabama at University of Alabama at Birmingham
    Birmingham, Alabama 35233
    Sarcoma
    Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
    Children's Hospital of Alabama at University of Alabama at Birmingham
    Birmingham, Alabama 35233
    Sarcoma
    Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
    Children's Hospital of Alabama at University of Alabama at Birmingham
    Birmingham, Alabama 35233
    Lymphoma
    Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma
    University of Alabama at Birmingham/ Kirklin Clinic Comprehensive CancerCenter (1)
    Birmingham, Alabama 35294-0006
    Renal Cell Carcinoma
    Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
    Children's Hospital of Alabama at University of Alabama at Birmingham
    Birmingham, Alabama 35233
    Neuroblastoma
    Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma
    University of Alabama, Birmingham
    Birmingham, Alabama 35233
    Head and Neck Squamous Cell Carcinoma
    Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Breast Cancer
    A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain

    Birmingham, Alabama 35294
    Pain, Burning, Pain, Crushing, Pain, Migratory, Pain, Radiating, Pain, Splitting
    Enhancing Physical Activity Adherence After Breast Cancer Diagnosis (BEAT Cancer II)
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Breast Cancer
    Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Childhood Central Nervous System Choriocarcinoma, Childhood Central Nervous System Embryonal Tumor, Childhood Central Nervous System Germ Cell Tumor, Childhood Central Nervous System Germinoma, Childhood Central Nervous System Mixed Germ Cell Tumor, Childhood Central Nervous System Teratoma, Childhood Central Nervous System Yolk Sac Tumor, Metastatic Childhood Soft Tissue Sarcoma, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Central Nervous System Embryonal Tumor, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Childhood Visual Pathway Glioma, Unspecified Childhood Solid Tumor, Protocol Specific
    Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Breast Cancer
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Diffuse Hyperplastic Perilobar Nephroblastomatosis, Rhabdoid Tumor of the Kidney, Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor, Stage IV Wilms Tumor, Stage V Wilms Tumor